Physician profile
Vagmin Vora
NPI 1679597447
$2,199.62
in general payments reported to CMS, 2019-2025
23 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2020: $406 · 2021: $49.57 · 2022: $1,009 · 2023: $33.15 · 2024: $81.06 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $223.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $435.09 | 2022 | |
| Stryker Corporation | $373.26 | 2019-2023 | Vitoss |
| Si-Bone, INC. | $274.35 | 2019-2023 | |
| Paragon 28, INC. | $266.22 | 2022 | |
| Providence Medical Technology, INC. | $173.73 | 2022 | |
| Orthofix Medical, INC. | $145.68 | 2019-2022 | |
| Royal Biologics, INC. | $142.73 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $99.58 | 2024-2025 | |
| Spinal Elements, INC. | $28.66 | 2022 | |
| Nuvasive, INC. | $25.85 | 2019 | |
| Nevro Corp. | $24.79 | 2024 | Senza |
| Depuy Synthes Sales INC. | $21.73 | 2019 | |
| Horizon Therapeutics Plc | $21.61 | 2022 | |
| Spine Wave, INC. | $21.49 | 2025 | Spinal Implant |
| Abbvie INC. | $20.22 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgalign Spine Technologies, INC. | $19.37 | 2020 | |
| Boston Scientific Corporation | $17.99 | 2022 | |
| Medtronic, INC. | $16.80 | 2025 | Cd Horizon Spinal System |
| Arteriocyte Medical Systems, INC. | $16.43 | 2021 | |
| Amgen INC. | $14.47 | 2024 | Krystexxa |
| Spineology INC. | $14.14 | 2020 | |
| Valinor Pharma, LLC | $13.28 | 2024 | Movantik |
| Avanos Medical | $12.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vagmin Vora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.